L. Murray

发表

Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke

K. Kadler, M. Abramowicz, N. van Regemorter, 2013, Human molecular genetics.

4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease

K. Kadler, A. Dean, K. Horsburgh, 2018, Human molecular genetics.

The Impact of 2018 Tariffs on U.S. Trade Values Across Relevant Categories

L. Murray, 2019 .

ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice

U. Schlötzer-Schrehardt, K. Kadler, J. Mullins, 2016, Disease Models & Mechanisms.

High fat diet and the colonic mucus barrier: implications for obesity and inflammatory bowel disease

S. Hasnain, M. McGuckin, H. Tong, 2015 .

Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome.

C. Packard, J. Shepherd, D. Grierson, 1992, Clinical science.

The Chemical Chaperone, PBA, Reduces ER Stress and Autophagy and Increases Collagen IV α5 Expression in Cultured Fibroblasts From Men With X-Linked Alport Syndrome and Missense Mutations

J. Savige, S. Ricardo, R. Tan, 2017, Kidney international reports.

Edinburgh Research Explorer ER-stress and basement membrane defects combine to cause glomerular and tubular renal disease caused by Col4a1 mutations

U. Schlötzer-Schrehardt, K. Kadler, J. Mullins, 2016 .

High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22

A. Perkins, S. Hasnain, M. McGuckin, 2016, Scientific Reports.

Fibre Intake Is Independently Associated with Increased Circulating Interleukin-22 in Individuals with Metabolic Syndrome

J. Coombes, Joyce S. Ramos, S. Hasnain, 2019, Nutrients.

Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized Trial

J. Coombes, L. Dalleck, Joyce S. Ramos, 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.

The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse

S. Hasnain, M. McGuckin, R. Steptoe, 2017, Diabetologia.